<?xml version="1.0"?>
<ichicsr lang="en">
  <ichicsrmessageheader>
    <messagetype>ICSR</messagetype>
    <messageformatversion>2.1</messageformatversion>
    <messageformatrelease>1.0</messageformatrelease>
    <messagenumb>2019-07</messagenumb>
    <messagesenderidentifier>FDA CDER</messagesenderidentifier>
    <messagereceiveridentifier>Public Use</messagereceiveridentifier>
    <messagedateformat>204</messagedateformat>
    <messagedate>20190713030751</messagedate>
  </ichicsrmessageheader>
  <safetyreport>
    <safetyreportversion>5</safetyreportversion>
    <safetyreportid>10036197</safetyreportid>
    <primarysourcecountry>AU</primarysourcecountry>
    <occurcountry>AU</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>20190711</transmissiondate>
    <reporttype>1</reporttype>
    <serious>1</serious>
    <seriousnessother>1</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>20140325</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>20190520</receiptdate>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb>AU-PFIZER INC-2014084855</companynumb>
    <duplicate>1</duplicate>
    <reportduplicate>
      <duplicatesource>PFIZER</duplicatesource>
      <duplicatenumb>AU-PFIZER INC-2014084855</duplicatenumb>
    </reportduplicate>
    <primarysource>
      <reportercountry>AU</reportercountry>
      <qualification>5</qualification>
    </primarysource>
    <sender>
      <sendertype>2</sendertype>
      <senderorganization>FDA-Public Use </senderorganization>
    </sender>
    <receiver>
      <receivertype>6</receivertype>
      <receiverorganization>FDA</receiverorganization>
    </receiver>
    <patient>
      <patientonsetage>45</patientonsetage>
      <patientonsetageunit>801</patientonsetageunit>
      <patientsex>1</patientsex>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Mania</reactionmeddrapt>
        <reactionoutcome>3</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Violence-related symptom</reactionmeddrapt>
        <reactionoutcome>3</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization>1</drugcharacterization>
        <medicinalproduct>ZOLOFT</medicinalproduct>
        <drugauthorizationnumb>019839</drugauthorizationnumb>
        <drugstructuredosagenumb>200</drugstructuredosagenumb>
        <drugstructuredosageunit>003</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
        <drugdosagetext>200 MG, 1X/DAY</drugdosagetext>
        <drugadministrationroute>048</drugadministrationroute>
        <drugindication>DEPRESSION</drugindication>
        <actiondrug>4</actiondrug>
        <activesubstance>
          <activesubstancename>SERTRALINE HYDROCHLORIDE</activesubstancename>
        </activesubstance>
      </drug>
    </patient>
  </safetyreport>
  <safetyreport>
    <safetyreportversion>9</safetyreportversion>
    <safetyreportid>10101342</safetyreportid>
    <primarysourcecountry>US</primarysourcecountry>
    <occurcountry>US</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>20190711</transmissiondate>
    <reporttype>1</reporttype>
    <serious>2</serious>
    <receivedateformat>102</receivedateformat>
    <receivedate>20140424</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>20190502</receiptdate>
    <fulfillexpeditecriteria>2</fulfillexpeditecriteria>
    <companynumb>US-PFIZER INC-2014113165</companynumb>
    <duplicate>1</duplicate>
    <reportduplicate>
      <duplicatesource>PFIZER</duplicatesource>
      <duplicatenumb>US-PFIZER INC-2014113165</duplicatenumb>
    </reportduplicate>
    <primarysource>
      <reportercountry>US</reportercountry>
      <qualification>1</qualification>
    </primarysource>
    <sender>
      <sendertype>2</sendertype>
      <senderorganization>FDA-Public Use </senderorganization>
    </sender>
    <receiver>
      <receivertype>6</receivertype>
      <receiverorganization>FDA</receiverorganization>
    </receiver>
    <patient>
      <patientweight>100</patientweight>
      <patientsex>2</patientsex>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Drug ineffective</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Drug intolerance</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Drug hypersensitivity</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization>2</drugcharacterization>
        <medicinalproduct>DICLOFENAC</medicinalproduct>
        <drugdosagetext>UNK</drugdosagetext>
        <activesubstance>
          <activesubstancename>DICLOFENAC</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization>1</drugcharacterization>
        <medicinalproduct>GABAPENTIN.</medicinalproduct>
        <drugauthorizationnumb>020235</drugauthorizationnumb>
        <drugdosagetext>UNK</drugdosagetext>
        <drugindication>NEURALGIA</drugindication>
        <actiondrug>4</actiondrug>
        <activesubstance>
          <activesubstancename>GABAPENTIN</activesubstancename>
        </activesubstance>
      </drug>
      <drug>
        <drugcharacterization>2</drugcharacterization>
        <medicinalproduct>ULTRAM</medicinalproduct>
        <drugstructuredosagenumb>50</drugstructuredosagenumb>
        <drugstructuredosageunit>003</drugstructuredosageunit>
        <drugseparatedosagenumb>1</drugseparatedosagenumb>
        <drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
        <drugintervaldosagedefinition>804</drugintervaldosagedefinition>
        <drugdosagetext>50 MG, 1X/DAY</drugdosagetext>
        <activesubstance>
          <activesubstancename>TRAMADOL HYDROCHLORIDE</activesubstancename>
        </activesubstance>
      </drug>
    </patient>
  </safetyreport>
  <safetyreport>
    <safetyreportversion>12</safetyreportversion>
    <safetyreportid>10101918</safetyreportid>
    <primarysourcecountry>CA</primarysourcecountry>
    <occurcountry>CA</occurcountry>
    <transmissiondateformat>102</transmissiondateformat>
    <transmissiondate>20190711</transmissiondate>
    <reporttype>1</reporttype>
    <serious>1</serious>
    <seriousnesshospitalization>1</seriousnesshospitalization>
    <seriousnessother>1</seriousnessother>
    <receivedateformat>102</receivedateformat>
    <receivedate>20140424</receivedate>
    <receiptdateformat>102</receiptdateformat>
    <receiptdate>20190518</receiptdate>
    <fulfillexpeditecriteria>1</fulfillexpeditecriteria>
    <companynumb>CA-ROCHE-1387978</companynumb>
    <duplicate>1</duplicate>
    <reportduplicate>
      <duplicatesource>ROCHE</duplicatesource>
      <duplicatenumb>CA-ROCHE-1387978</duplicatenumb>
    </reportduplicate>
    <primarysource>
      <reportercountry>CA</reportercountry>
      <qualification>5</qualification>
    </primarysource>
    <sender>
      <sendertype>2</sendertype>
      <senderorganization>FDA-Public Use </senderorganization>
    </sender>
    <receiver>
      <receivertype>6</receivertype>
      <receiverorganization>FDA</receiverorganization>
    </receiver>
    <patient>
      <patientonsetage>70</patientonsetage>
      <patientonsetageunit>801</patientonsetageunit>
      <patientsex>1</patientsex>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Cough</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Sinusitis</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Smoke sensitivity</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Cholelithiasis</reactionmeddrapt>
        <reactionoutcome>1</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Hypoventilation</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Pyrexia</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Nasopharyngitis</reactionmeddrapt>
        <reactionoutcome>1</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Perfume sensitivity</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Dust allergy</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Body temperature decreased</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Vertigo</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Blood pressure increased</reactionmeddrapt>
        <reactionoutcome>3</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Nausea</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Middle insomnia</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Osteoarthritis</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Hypersensitivity</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Asthma</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <reaction>
        <reactionmeddraversionpt>22.0</reactionmeddraversionpt>
        <reactionmeddrapt>Dizziness</reactionmeddrapt>
        <reactionoutcome>6</reactionoutcome>
      </reaction>
      <drug>
        <drugcharacterization>1</drugcharacterization>
        <medicinalproduct>XOLAIR</medicinalproduct>
        <drugbatchnumb> S0058A,UNKNOWN,UNKNOWN,UNKNOWN,S005</drugbatchnumb>
        <drugauthorizationnumb>103976</drugauthorizationnumb>
        <drugdosageform>SOLUTION FOR INJECTION</drugdosageform>
        <drugadministrationroute>058</drugadministrationroute>
        <drugstartdateformat>102</drugstartdateformat>
        <drugstartdate>20160218</drugstartdate>
        <actiondrug>5</actiondrug>
